Profile of:

Denis Poddubnyy

Full name: Denis Poddubnyy

Current country: Germany

Membership level: Full

Type of membership: EC

Number of publications: 23

[Spondyloarthritis in childhood and adulthood] (2022)

Diagnostic evaluation of the sacroiliac joints for axial spondyloarthritis: should MRI replace radiography? (2022)

Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort (2022)

Deep Learning Detects Changes Indicative of Axial Spondyloarthritis at MRI of Sacroiliac Joints (2022)

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) (2021)

Characteristics of Patients With Axial Spondyloarthritis by Geographic Regions: PROOF Multicountry Observational Study Baseline Results (2021)

[Perioperative management of treatment of patients with inflammatory rheumatic diseases : Updated recommendations of the German Society of Rheumatology] (2021)

Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial (2021)

Impact of axial spondyloarthritis on mental health in Europe: results from the EMAS study (2021)

Rapid improvement in spinal pain in patients with axial spondyloarthritis treated with secukinumab: primary results from a randomized controlled phase-IIIb trial (2021)

Detection of radiographic sacroiliitis with an artificial neural network in patients with suspicion of axial spondyloarthritis (2021)

Relation of α 2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis (2020)

The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study (2020)

Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis (2020)

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate (2020)

The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study (2020)

Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa (2020)

Patient-reported Impact of Axial Spondyloarthritis on Working Life: Results from the EMAS survey (2020)

Assessment of radiographic sacroiliitis in anteroposterior lumbar vs conventional pelvic radiographs in axial spondyloarthritis (2020)

Treatment of Axial Spondyloarthritis: What Does the Future Hold? (2020)

Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritis (2020)

IgA antibodies against CD74 are associated with structural damage in the axial skeleton in patients with axial spondyloarthritis (2020)

Axial spondyloarthritis (2017)